Microcrystalline Tyrosine (MCT(®)): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in Malaria

Microcrystalline Tyrosine (MCT(®)) is a widely used proprietary depot excipient in specific immunotherapy for allergy. In the current study we assessed the potential of MCT to serve as an adjuvant in the development of a vaccine against malaria. To this end, we formulated the circumsporozoite protei...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Vaccines (Basel)
Autori principali: Cabral-Miranda, Gustavo, Heath, Matthew D., Gomes, Ariane C., Mohsen, Mona O., Montoya-Diaz, Eduardo, Salman, Ahmed M., Atcheson, Erwan, Skinner, Murray A., Kramer, Matthias F., Reyes-Sandoval, Arturo, Bachmann, Martin F.
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2017
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5748599/
https://ncbi.nlm.nih.gov/pubmed/28953265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines5040032
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi